Literature DB >> 29059315

The Use of Botulinum Toxin to Treat Infantile Esotropia: A Systematic Review With Meta-Analysis.

Dayane Cristine Issaho1,2, Fabio Ramos de Souza Carvalho2, Marcia Keiko Uyeno Tabuse2, Linda Christian Carrijo-Carvalho2, Denise de Freitas2.   

Abstract

Purpose: The purpose of this review was to examine the efficacy of botulinum toxin in the treatment of infantile esotropia and to evaluate the average response of BT and its complication rates.
Methods: A research was performed in the Latin American and Caribbean Literature on Health Sciences (LILACS), MEDLINE, and Cochrane Central Register of Controlled Trial (CENTRAL). The database was searched between December 28, 2016 and January 30, 2017. The selection was restricted to articles published in English, Spanish, or Portuguese. There were no date restrictions in the search.
Results: Nine studies were eligible for inclusion. The grouped success rate of BT treatment in infantile esotropia was 76% (95% confidence interval [CI]: 61%-89%). For the success rate, I2 of 94.25% was observed, indicating a high heterogeneity (P < 0.001). The complication rates were also analyzed. The grouped consecutive exotropia (XT) rate was 1% (95% CI: 0%-2%). The grouped ptosis rate was 27% (95% CI: 21%-33%). The grouped vertical deviation rate was 12% (95% CI: 4%-22%). The mean change of the deviation after BT injection was -30.7 (95% CI: -37.7, -23.8), demonstrating a significant improvement in alignment. Conclusions: Botulinum toxin injection into medial recti muscles reveals to be a safe procedure and a valuable alternative to strabismus surgery in congenital esotropia, especially in moderate deviations.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29059315     DOI: 10.1167/iovs.17-22576

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

Review 1.  Interventions for eye movement disorders due to acquired brain injury.

Authors:  Fiona J Rowe; Kerry Hanna; Jennifer R Evans; Carmel P Noonan; Marta Garcia-Finana; Caroline S Dodridge; Claire Howard; Kathryn A Jarvis; Sonia L MacDiarmid; Tallat Maan; Lorraine North; Helen Rodgers
Journal:  Cochrane Database Syst Rev       Date:  2018-03-05

2.  Short-term outcome of botulinum neurotoxin A injection with or without sodium hyaluronate in the treatment of infantile esotropia-a prospective interventional study.

Authors:  Nitika Pandey; Siddharth Agrawal; Rajat M Srivastava; Vinita Singh
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

3.  Cost comparison between botulinum neurotoxin and surgery in the treatment of infantile esotropia in a tertiary public hospital.

Authors:  Ismail Mayet; Shelley-Ann McGee; Naseer Ally; Hassan Dawood Alli; Mohammed Tikly; Susan Eileen Williams
Journal:  BMJ Open Ophthalmol       Date:  2021-06-21

4.  Botulinum toxin chemodenervation for childhood strabismus in England: National and local patterns of practice.

Authors:  Ameenat Lola Solebo; Anne-Marie Austin; Maria Theodorou; Chris Timms; Joanne Hancox; Gillian G W Adams
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

Review 5.  Stereopsis: are we assessing it in enough depth?

Authors:  Anna R O'Connor; Laurence P Tidbury
Journal:  Clin Exp Optom       Date:  2018-01-27       Impact factor: 2.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.